Cassava is available year round. It’s quite hard to peel, so it’s easiest to buy it ready prepared and frozen. If you do see it fresh, look for a clear outer skin and white flesh. Cassava ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As a foodstuff, nardoo is a curiosity. The same cannot be said of cassava roots, which are a vital source of calories in many tropical countries, particularly for subsistence farmers in Africa.

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.

Claude Nicaise, M.D. appointed Chairman of the BoardAUSTIN, Texas, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s ...

While sparse data makes accurate measurement difficult, most would agree violence and lawlessness are increasing in many parts of PNG. The broader context for this violence includes: rural decay ...

The construction of a multibillion cassava processing factory project in Acholibur town council, Pader District remains uncertain for seven years after government of Uganda through the Uganda ...

Cassava Sciences, Inc. (NASDAQ: SAVA) saw its stock price soar by 15.5% to $27.13, an increase of $3.64, amid rising short interest and an anticipated conference call to discuss recent ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Short interest in Cassava Sciences Inc (NASDAQ:SAVA) decreased during the last reporting period, falling from 17.68M to 15.81M. This put 35.18% of the company's publicly available shares short.